Page 51 - Definitive Proxy Statement News Today

Home / Top News / Ocugen Inc. Announces Plan to Adjourn Annual Meeting of Stockholders, Modify Proposal Regarding Increase in Number of Authorized Shares Ocugen Inc. Announces Plan to Adjourn Annual Meeting of Stockholders, Modify Proposal Regarding Increase in Number of Authorized Shares Annual Meeting to be adjourned solely with respect to Item 2, and Item 2 to be modified to decrease the proposed aggregate number of shares of common stock that the Company would be authorized to issue from 50...

Megalith Financial Acquisition Corp. Stockholders Approve Business Combination with BankMobile Technologies, Inc. December 21, 2020 21:42 ET | Source: Megalith Financial Acquisition Corp Megalith Financial Acquisition Corp NEW YORK, NY, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Megalith Financial Acquisition Corp. (the “Company” or “MFAC”) (NYSE American: MFAC, MFAC.W, MFAC.U), a special purpose acquisition company, today held its previously announced special meeting ...

Viasat Announces Definitive Agreement to Acquire RigNet - Acquisition Expected to Expand and Diversify Viasats Commercial Connectivity Portfolio, Add Complementary Technology and Align with Viasats Global Operations Ahead of the ViaSat-3 Satellite Constellation Launch - Investor Conference Call Scheduled for Monday, December 21, 2020 at 8:30 a.m. Eastern Time News provided by Share this article Share this article CARLSBAD, Calif., Dec. 21, 2020 /PRNewswire/ -- Viasat Inc. (NASDAQ: VSAT), a glo...

Greenland Technologies Ramps to Over 800 Units in Monthly Sales of New Integrated Drive Train System for Electric Forklift Trucks Represents Companys Fastest New Product Ramp News provided by Share this article Share this article HOWELL, N.J., Dec. 21, 2020 /PRNewswire/ -- Greenland Technologies Holding Corporation (NASDAQ: GTEC) ("Greenland"), a technology developer and manufacturer of forklift transmission and drivetrain systems, announced today strong initial sales of the Companys new integ...

Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement Merger brings lead compound CM-101, a first in class anti-CCL24 antibody into advanced clinical development for fibrosis-related diseases with significant unmet medical need Concurrent PIPE financing to be used to fund clinical trials for CM-101 in fibrotic indications, focusing on two rare diseases and backed by leading healthcare...